Correvio Pharma Corp. Financing Cash Flow
Correvio Pharma Corp. reported Financing Cash Flow of $24.64 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2020-04-30
| Period end | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|
| 2019-12-31 | $24.64M 20-F · filed 2020-04-30 | |
| 2018-12-31 | $5.38M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $24.40M 20-F · filed 2020-04-30 | |
| 2016-12-31 | $38.47M 20-F · filed 2018-04-30 | $38.56M 40-F · filed 2017-03-29 |
| 2015-12-31 | $21.78M 20-F · filed 2018-04-30 | $21.82M 40-F · filed 2016-03-29 |
| 2014-12-31 | $20.97M 40-F · filed 2016-03-29 | |
| 2013-12-31 | -$12.84M 40-F · filed 2015-03-27 | |
| 2012-12-31 | $18.07M 40-F/A · filed 2014-04-30 | |
| 2011-12-31 | $358.00K 20-F/A · filed 2013-04-18 | |
| 2010-12-31 | $27.36M 20-F/A · filed 2013-04-18 |